Gelatin nanocarriers as potential vectors for effective management of tuberculosis GK Saraogi, P Gupta, UD Gupta, NK Jain, GP Agrawal International journal of pharmaceutics 385 (1-2), 143-149, 2010 | 200 | 2010 |
Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting N Nimje, A Agarwal, GK Saraogi, N Lariya, G Rai, H Agrawal, GP Agrawal Journal of drug targeting 17 (10), 777-787, 2009 | 162 | 2009 |
Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis GK Saraogi, B Sharma, B Joshi, P Gupta, UD Gupta, NK Jain, GP Agrawal Journal of drug targeting 19 (3), 219-227, 2011 | 134 | 2011 |
Self-emulsifying oral lipid drug delivery systems: advances and challenges S Rani, R Rana, GK Saraogi, V Kumar, U Gupta AAPS pharmscitech 20 (3), 129, 2019 | 115 | 2019 |
Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities GS Kiran Patil⁎, Shashikant Bagade, Smita Bonde, Sanjay Sharma Biomedicine & Pharmacotherapy 99, 735-745, 2018 | 95 | 2018 |
Nanoparticles as novel carrier for brain delivery: a review A Agarwal, N Lariya, G Saraogi, N Dubey, H Agrawal, GP Agrawal Current Pharmaceutical Design 15 (8), 917-925, 2009 | 82 | 2009 |
Formulation and evaluation of multipurpose herbal cream J Modi, S Rathore, S Dwivedi, G Saraogi International Journal of Newgen Research in Pharmacy & Healthcare, 129-134, 2024 | 59 | 2024 |
Preparation and evaluation of the self-emulsifying drug delivery system containing atorvastatin HMG-CoA inhibiter R Chouksey, H Pandey, AK Jain, H Soni, GK Saraogi Int J Pharm Pharm Sci 3 (3), 147-152, 2011 | 54 | 2011 |
Polymeric micelles: a ray of hope among new drug delivery systems A Kapse, N Anup, V Patel, GK Saraogi, DK Mishra, RK Tekade Drug Delivery Systems, 235-289, 2020 | 49 | 2020 |
3D printing technology: a new milestone in the development of pharmaceuticals A Chandekar, DK Mishra, S Sharma, GK Saraogi, U Gupta, G Gupta Current pharmaceutical design 25 (9), 937-945, 2019 | 47 | 2019 |
Smart dendrimers: Synergizing the targeting of anticancer bioactives V Saluja, A Mankoo, GK Saraogi, MM Tambuwala, V Mishra Journal of Drug Delivery Science and Technology 52, 15-26, 2019 | 44 | 2019 |
Current trends in theranostic nanomedicines MB Shete, TS Patil, AS Deshpande, G Saraogi, N Vasdev, M Deshpande, ... Journal of Drug Delivery Science and Technology 71, 103280, 2022 | 39 | 2022 |
Advances in thermo-responsive polymers exhibiting upper critical solution temperature (UCST). KK Bansal, PK Upadhyay, GK Saraogi, A Rosling, JM Rosenholm eXPRESS Polymer Letters 13 (11), 2019 | 32 | 2019 |
Galactose decorated PLGA nanoparticles for hepatic delivery of acyclovir S Gupta, A Agarwal, NK Gupta, G Saraogi, H Agrawal, GP Agrawal Drug development and industrial pharmacy 39 (12), 1866-1873, 2013 | 31 | 2013 |
Dendrimer based nanoarchitectures in diabetes management: An overview V Mishra, N Yadav, GK Saraogi, MM Tambuwala, N Giri Current Pharmaceutical Design 25 (23), 2569-2583, 2019 | 29 | 2019 |
Formulation development and evaluation of pravastatin-loaded nanogel for hyperlipidemia management GK Saraogi, S Tholiya, Y Mishra, V Mishra, A Albutti, P Nayak, ... Gels 8 (2), 81, 2022 | 26 | 2022 |
The future of pharmaceutical product development and research RK Tekade Academic Press, 2020 | 26 | 2020 |
Nutraceuticals-an emerging era in the treatment and prevention of diseases A Singh, R Dubey, RT Paliwal, GK Saraogi, AK Singhai International Journal of Pharmacy and Pharmaceutical Sciences 4 (4), 39-43, 2012 | 24 | 2012 |
Nano drug delivery strategies for the treatment of cancers AK Yadav, U Gupta, R Sharma Academic Press, 2020 | 22 | 2020 |
Development and evaluation of sustained release matrix tablet of lamivudine S Jain, NK Mehra, AK Singhai, GK Saraogi IJPSR 2 (1), 454-61, 2011 | 21 | 2011 |